INFI) is a drug discovery and development company in which institutional investors hold 98 percent of its outstanding shares. Infinity has had a rough go over the last year since its $24.00 peak. However, the stock has turned around from …
INFI) and CSX Corp (NYSE: CSX) are all expected to be higher leading up to their next earnings release. The …
Infinis Energy has started trading on the London Stock Exchange's main market under the ticker INFI. The company says its entire ordinary share capital of 300,000,000 shares has been admitted to the premium listing segment of the …
A year ago, they were trading at 93 cents. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INFI at …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INFI at https://www.zacks.com/ap/INFI Keywords: Infinity …
The share price of American Capital Mortgage Investment Crp ... The stock is trading 17.7% above its 50-day moving average and 18.8% above its 200-day moving average. While trading on below-average volume, Infinity Pharmaceuticals …